{ "tag": [ "compiled" ], "id": "ocds-h6vhtk-0361f9-2022-08-23T11:17:50+01:00", "date": "2022-08-23T11:17:50+01:00", "ocid": "ocds-h6vhtk-0361f9", "initiationType": "tender", "tender": { "id": "DN628672", "legalBasis": { "id": "32014L0024", "scheme": "CELEX" }, "title": "(NU/1804) Research Agreement between Newcastle University and Antaros Medical AB", "status": "complete", "classification": { "scheme": "CPV", "id": "73110000", "description": "Research services" }, "mainProcurementCategory": "services", "description": "The services required are the analysis of MRI endpoints for a natural history study in subjects with liver disease. Intention to award a research contract under UK Statutory Instrument 2015 No. 102 Part 2 Chapter 2 Section 3 Regulation 32(1)(b)(ii) and (iii) for provision of MRI analysis to support a natural history cohort study in subjects with liver disease. The contracting party will support deployment, acquisition and downstream analysis of MR imaging modalities including but not limited to 2/3D MRE and contrast enhanced MRI, including the use of their own proprietary techniques, to assess liver structure and function and support clinical research.", "lots": [ { "id": "1", "description": "The services required are the analysis of MRI endpoints for a natural history study in subjects with liver disease. Intention to award a research contract under UK Statutory Instrument 2015 No. 102 Part 2 Chapter 2 Section 3 Regulation 32(1)(b)(ii) and (iii) for provision of MRI analysis to support a natural history cohort study in subjects with liver disease. The contracting party will support deployment, acquisition and downstream analysis of MR imaging modalities including but not limited to 2/3D MRE and contrast enhanced MRI, including the use of their own proprietary techniques, to assess liver structure and function and support clinical research.", "hasOptions": true, "options": { "description": "Future option to develop proprietary PET-tracers targeting Collagen-1 and PDGFRbeta that may be relevant in a future extension of the scope of this project." } } ], "items": [ { "id": "1", "additionalClassifications": [ { "scheme": "CPV", "id": "73111000", "description": "Research laboratory services" } ], "deliveryAddresses": [ { "region": "UKC22" } ], "relatedLot": "1" } ], "procurementMethod": "limited", "procurementMethodDetails": "Award procedure without prior publication of a call for competition", "coveredBy": [ "GPA" ], "reviewDetails": "Newcastle University will incorporate a minimum 10 calendar day standstill period at the point information on the award of the contract is communicated to tenderers. This period allows unsuccessful tenderers to seek further debriefing before the contract is entered into. Applicants have 2 working days from notification of the award decision to request additional debriefing and 4 / 4 that information has to be provided a minimum of 3 working days before expiry of the standstill period. Such additional information should be requested from the address referred to in part 1.1 above. If an appeal regarding the award of a contract has not been successfully resolved, the Public Contracts Regulations 2015 provide for aggrieved parties who have been harmed or are at risk of harm by a breach of the rules to take action in the High Court (England, Wales and Northern Ireland). Any such action must be brought promptly. Where a contract has not been entered into the Court may order the setting aside of the award decision or order the authority to amend any document and may award damages. If the contract has been entered into the Court may only award damages.", "procurementMethodRationaleClassifications": [ { "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL", "id": "D_OUTSIDE_SCOPE", "description": "The procurement falls outside the scope of application of the directive" } ], "procurementMethodRationale": "The intention is to award a research contract under UK Statutory Instrument 2015 No. 102 Part 2 Chapter 2 Section 3 Regulation 32(1)(b)(ii) and (iii). Where (ii) is the justification for technical reasons and (iii) is the protection of exclusive rights, including intellectual property rights. Antaros Medical have established expertise and experience of deploying advanced MR methodologies in studies that seek to investigate not only liver morphology but also downstream consequences of liver fibrosis such as liver function, portal pressure (including pressure effects on the spleen and portal resistive index) and blood flow to the spleen and kidneys. A range of imaging modalities will be employed in this project including but not limited to liver and spleen stiffness using 2/3D MRE and liver function using uptake of MRI contrast agents, where Antaros Medical have developed quantitative modelling of uptake kinetics to assess liver transporter function. Antaros Medical are also developing proprietary PET-tracers targeting Collagen-1 and PDGFRbeta that may be relevant in a future extension of the scope of this project. These tracers are Antaros Medical proprietary investigational products. Antaros medical will support deployment, acquisition and downstream analysis of MR imaging modalities including but not limited to 2/3D MRE and contrast enhanced MRI to assess liver structure and function and support the research project. In addition, Antaros Medical will collaborate as required with the academic investigators to support the downstream analysis of data, sharing know-how of advanced imaging." }, "awards": [ { "id": "023436-2022-NU/1804-1", "relatedLots": [ "1" ], "title": "(NU/1804) Research Agreement between Newcastle University and Antaros Medical AB", "status": "active", "suppliers": [ { "id": "GB-FTS-62082", "name": "Antaros Medical AB" } ] } ], "parties": [ { "id": "GB-FTS-168", "name": "Newcastle University", "identifier": { "legalName": "Newcastle University" }, "address": { "streetAddress": "Newcastle University, Procurement Services, Kingsgate", "locality": "Newcastle", "region": "UKC22", "postalCode": "NE1 7RU", "countryName": "United Kingdom" }, "contactPoint": { "name": "Dr Emma Barksby", "telephone": "+44 1912086298", "email": "emma.barksby@ncl.ac.uk" }, "roles": [ "buyer" ], "details": { "url": "https://www.ncl.ac.uk", "buyerProfile": "https://www.ncl.ac.uk", "classifications": [ { "scheme": "TED_CA_TYPE", "id": "BODY_PUBLIC", "description": "Body governed by public law" }, { "scheme": "COFOG", "id": "09", "description": "Education" } ] } }, { "id": "GB-FTS-62082", "name": "Antaros Medical AB", "identifier": { "legalName": "Antaros Medical AB" }, "address": { "streetAddress": "Bio Venture Hub, Pepparedsleden 1", "locality": "431 83 Molndal", "region": "SE", "countryName": "Sweden" }, "roles": [ "supplier" ], "details": { "scale": "sme" } }, { "id": "GB-FTS-7395", "name": "Newcastle University", "identifier": { "legalName": "Newcastle University" }, "address": { "locality": "Newcastle upon Tyne", "countryName": "United Kingdom" }, "roles": [ "reviewBody" ], "details": { "url": "https://www.ncl.ac.uk" } } ], "buyer": { "id": "GB-FTS-168", "name": "Newcastle University" }, "contracts": [ { "id": "023436-2022-NU/1804-1", "awardID": "023436-2022-NU/1804-1", "title": "(NU/1804) Research Agreement between Newcastle University and Antaros Medical AB", "status": "active", "dateSigned": "2022-08-18T00:00:00+01:00" } ], "bids": { "statistics": [ { "id": "3", "measure": "lowestValidBidValue", "relatedLot": "1", "value": 3000000, "currency": "GBP" }, { "id": "4", "measure": "highestValidBidValue", "relatedLot": "1", "value": 6000000, "currency": "GBP" }, { "id": "1", "measure": "lowestValidBidValue", "value": 3000000, "currency": "GBP" }, { "id": "2", "measure": "highestValidBidValue", "value": 6000000, "currency": "GBP" } ] }, "language": "en" }